XRAY - Earnings announcements

CHARLOTTE, N.C., April 22, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company will host an investor conference call and live webcast on Tuesday, May 5, 2026, at 4:30 p.m. ET to review its first quarter 2026 financial results. Financial earnings materials will be made available on the Investors section of the Company's website at https://investor.dentsplysirona.com prior to the call. Conference Call / Webcast Information The live webcast link and call information will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. For those planning to participate on the c

News Summary Q4 2025 net sales of $961 million increased 6.2%, constant currency sales increased 2.5%Q4 2025 reported net loss of ($146) million and diluted loss per share of ($0.74) driven by goodwill and intangible impairments of ($144) million, net of taxQ4 2025 adjusted EPS of $0.27FY 2026 outlook: net sales in the range of $3.5B to $3.6B; adjusted EPS of $1.40 to $1.50(1)Announced a restructuring initiative to redirect approximately $120 million annually into the Return-to-Growth Action Plan, prioritizing investments in accelerated innovation, clinical education, and sales team education focused on connected dentistryInitiated new capital allocation strategy by eliminating the dividend

CHARLOTTE, N.C., Feb. 05, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company will host an investor conference call and live webcast on Thursday, February 26, 2026, at 4:30 p.m. EST to review its fourth quarter and full year 2025 financial results. The Company will issue a press release and provide a presentation with summary financial information, which will be made available on the Investors section of the Company's website at https://investor.dentsplysirona.com prior to the call. Conference Call / Webcast Information The live webcast will be available on the Investors section of the Company's website at http

Dentsply Sirona Reports Third Quarter 2025 Results Net sales of $904 million decreased (5.0%) as-reported, decreased (8.0%) in constant currency including (5.5%) driven by Q3 2024 Byte impact and ERP pre-buyGAAP gross margin of 48.8%, GAAP net loss per share of ($2.14)Adjusted gross margin of 52.6%, adjusted EBITDA margin of 18.4%, adjusted EPS of $0.37Revised FY25 outlook Executing its Return-to-Growth action plan to drive improved performance and deliver sustained, profitable growthProvides leadership updates to support transformation strategy CHARLOTTE, N.C., Nov. 06, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced its f

CHARLOTTE, N.C., Oct. 08, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company will host an investor conference call and live webcast on Thursday, November 6, 2025, at 8:30 am ET to review its financial results for the third quarter of fiscal year 2025. The Company will issue a press release and provide a presentation with summary financial information, which will be made available on the Investors section of the Company's website at https://investor.dentsplysirona.com prior to the call. Conference Call / Webcast Information The live webcast will be available on the Investors section of the Company's website at

CHARLOTTE, N.C., July 21, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or "the Company") (NASDAQ:XRAY) today announced that Daniel Scavilla, an established business leader with more than three decades of experience in the medical technology and pharmaceutical industries and a current member of the Board of Directors of Dentsply Sirona (the "Board"), has been appointed President and Chief Executive Officer, effective August 1, 2025. He succeeds Simon Campion, who is leaving the Company on July 31, 2025.  Mr. Scavilla recently served as President and Chief Executive Officer of Globus Medical, where he led the acquisition of NuVasive and oversaw the integration of the two

CHARLOTTE, N.C., July 10, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company will host an investor conference call and live webcast on Thursday, August 7, 2025, at 8:30 am ET to review its financial results for the second quarter of fiscal year 2025. The Company will issue a press release and provide a presentation with summary financial information, which will be made available on the Investors section of the Company's website at https://investor.dentsplysirona.com prior to the call. Conference Call / Webcast Information The live webcast will be available on the Investors section of the Company's website at h

Net sales of $879 million decreased (7.7%), organic sales decreased (4.4%) including a (4.0%) Byte sales impactGAAP gross margin of 53.0%, GAAP net income of $20 million or $0.10 per shareAdjusted gross margin of 56.3%, adjusted EBITDA margin of 19.0%, adjusted EPS of $0.43Maintaining FY25 outlook for organic sales and adjusted EPS; increasing reported sales due to F/X changes CHARLOTTE, N.C., May 08, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced its financial results for the first quarter of 2025. First quarter net sales of $879 million decreased (7.7%) (organic sales decreased (4.4%)) compared to the first quarter of 2

CHARLOTTE, N.C., April 09, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Thursday, May 8, 2025, at 8:30 am ET to review its first quarter financial results. A presentation related to the call will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. Conference Call / Webcast Information A live webcast will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. For those planning to participate on the call, please register at https://register-conf

FY24 net sales of $3,793 million decreased (4.3%), organic sales decreased (3.5%) including a (1.2%) Byte sales impactFY24 GAAP net loss of ($910) million or ($4.48) per share, adjusted EPS of $1.67Q4 net sales of $905 million decreased (10.6%), organic sales decreased (10.7%) including a (6.0%) Byte sales impactQ4 GAAP net loss of ($430) million or ($2.16) per share, adjusted EPS of $0.26FY25 outlook: net sales in the range of $3.50 billion to $3.60 billion with organic sales down (4.0%) to (2.0%); adjusted EPS of $1.80 to $2.00(1) CHARLOTTE, N.C., Feb. 27, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced its financial resul

CHARLOTTE, N.C., Feb. 11, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company has initiated a process to evaluate strategic alternatives for its Wellspect Healthcare business ("Wellspect"). Wellspect is a leading provider of bladder and bowel management care products with an over 40-year history. Through its comprehensive portfolio of products and accessories from trusted brands like LoFric® and Navina™, Wellspect has delivered improved organic sales growth in recent years, including mid-to-high single digit growth for 2023 and through the first three quarters of 2024. The business is well-positioned in the larg

CHARLOTTE, N.C., Jan. 27, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Thursday, February 27, 2025, at 8:30 am ET to review its fourth quarter and full year 2024 financial results. A presentation related to the call will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. Conference Call / Webcast Information A live webcast will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. For those planning to participate on the call, please register

Net sales of $951 million increased 0.5%, organic sales increased 1.3%GAAP gross margin of 52.1%, GAAP net loss of ($494) million or loss per share of ($2.46)Adjusted EBITDA margin of 17.9%, adjusted EPS of $0.50Revised FY24 outlook: expect organic sales of (3.5%) to (2.5%) (previously (1%) to flat); adjusted EPS of $1.82 to $1.86 (previously $1.96 to $2.02) CHARLOTTE, N.C., Nov. 07, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced its financial results for the third quarter of 2024. Third quarter net sales of $951 million increased 0.5% (organic sales increased 1.3%) compared to the third quarter

CHARLOTTE, N.C., Oct. 25, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced it will host a conference call to discuss its Byte Aligner business. Dentsply Sirona's management team will host an investor conference call and live webcast on October 25, 2024, at 9:00 am ET. For those planning to participate on the call, please register at https://register.vevent.com/register/BI91fb506c8c2944bca6e65629062dd357. A webcast replay of the conference call will be available on the Investors section of the Company's website following the call. About Dentsply Sirona Dentsply Sirona is the world's largest manufacturer of professional

Voluntarily Suspends Sales and Marketing of Byte Aligners and Impression Kits Provides Select Preliminary Third Quarter 2024 Results CHARLOTTE, N.C., Oct. 24, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY), today announced the voluntary suspension of sales and marketing of its Byte Aligners and Impression Kits while the Company conducts a review of certain regulatory requirements related to these products. The Company's decision was made in consultation with the U.S. Food and Drug Administration (FDA). In connection with this review, and Dentsply Sirona's proactive efforts to continuously improve its processes, the Comp

CHARLOTTE, N.C., Oct. 09, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Thursday, November 7, 2024, at 8:30 am ET to review its third quarter financial results. A presentation related to the call will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. Conference Call / Webcast Information A live webcast will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. For those planning to participate on the call, please register at https://register.

Net sales of $984 million decreased (4.2%), organic sales decreased (2.3%)GAAP gross margin of 51.9%, GAAP net loss of ($4) million or loss per share of ($0.02)Adjusted EBITDA margin of 17.5%, adjusted EPS of $0.49Revised FY24 outlook: organic sales down (1%) to flat (previously flat to up 1.5%); adjusted EPS of $1.96 to $2.02 (previously $2.00 to $2.10)Company repurchased $150 million of its common stock in Q2 2024; expects to repurchase $100 million of its common stock in Q3 2024Second phase of transformation includes an expected reduction in annualized operating expenses of $80 to $100 million over approximately 12 to 18 months CHARLOTTE, N.C., July 31, 2024 (GLOBE NEWSWIRE) -- D

CHARLOTTE, N.C., July 09, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Wednesday, July 31, 2024, at 8:30 am ET to review its second quarter financial results. A presentation related to the call will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. Conference Call / Webcast Information A live webcast will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. For those planning to participate on the call, please register at https://re

Net sales of $953 million decreased (2.6%), organic sales decreased (1.9%)GAAP gross margin of 53.1%, GAAP net income of $18 million or $0.09 per shareAdjusted EBITDA margin of 16.8%, adjusted EPS of $0.42Maintaining FY24 outlook for organic sales and adjusted EPS, trending towards the low-end of both ranges; reported sales adjusted for additional foreign currency impactCompany expects to repurchase up to $150 million of its common stock in Q2 2024 CHARLOTTE, N.C, May 02, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced its financial results for the first quarter of 2024. First quarter net sales of $953 million decreased (2.

CHARLOTTE, N.C., April 09, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Thursday, May 2, 2024, at 8:30 am ET to review its first quarter financial results. A presentation related to the call will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. Conference Call / Webcast Information A live webcast will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. For those planning to participate on the call, please register at https://register.veve

FY23 net sales of $3,965 million increased 1.1%, organic sales increased 2.2%FY23 GAAP net income (loss) of ($132) million or ($0.62) per share, adjusted EPS of $1.83Q4 net sales of $1,012 million increased 2.9%, organic sales increased 1.9%Q4 GAAP net income of $67 million or $0.32 per share, adjusted EPS of $0.44FY24 outlook: organic sales flat to up 1.5%; adjusted EPS of $2.00 to $2.10 CHARLOTTE, N.C., Feb. 29, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced its financial results for the fourth quarter and full year of 2023. Full year 2023 net sales of $3,965 million increased 1.1% (organic sales increased 2.2%), compar

CHARLOTTE, N.C., Jan. 29, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Thursday, February 29, 2024, at 8:30 am ET to review its fourth quarter and full year 2023 financial results. A presentation related to the call will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com.  Conference Call / Webcast Information A live webcast will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. For those planning to participate on the call, please registe

Net sales of $947 million were flat year-over-year, organic sales decreased (0.3%)GAAP gross margin of 52.2%, GAAP net loss of ($266) million or ($1.25) per shareAdjusted EBITDA margin of 18.2%, adjusted EPS of $0.49Revised FY23 outlook: organic sales growth of ~1% (from ~3%); adjusted EPS of $1.80 to $1.85 (from $1.92 to $2.02)Company expects to repurchase $150 million of its common stock in Q4 2023 CHARLOTTE, N.C., Nov. 02, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced its financial results for the third quarter of 2023. Third quarter net sales of $947 million were flat (organic sales decreased (0.3%)) compa

CHARLOTTE, N.C., Oct. 18, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Thursday, November 2, 2023, at 8:30 am ET to review its third quarter financial results. A presentation related to the call will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. Conference Call / Webcast Information A live webcast will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. For those planning to participate on the call, please register at https://register.

Net sales increased 0.5% to $1,028 million, organic sales increased 2.3%GAAP net income of $86 million, GAAP earnings per share of $0.40Adjusted EBITDA margin of 17.7%, adjusted EPS of $0.51Raising midpoint of FY23 net sales by $75 million to a range of $3.98 billion to $4.02 billionRaising FY23 organic sales growth outlook to approximately 3% (previously flat to up 2%)Raising FY23 adjusted EPS outlook to a range of $1.92 to $2.02 (previously $1.85 to $2.00) CHARLOTTE, N.C., Aug. 02, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced its financial results for the second quarter of 2023. Second quarter net sales of $1,028 milli

CHARLOTTE, N.C., July 12, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona") (NASDAQ:XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Thursday, August 3, 2023, at 8:30 am ET to review its second quarter financial results. A presentation related to the call will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. Conference Call / Webcast Information  A live webcast will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. For those planning to participate on the call, please register at https://register.vevent.com/regist

Net sales increased 0.9% to $978 million, organic sales increased 5.1%GAAP net loss of ($19) million, GAAP loss per share of ($0.09)Adjusted EBITDA of $161 million, adjusted EPS of $0.39Raising low-end of FY23 net sales outlook by $50 million and low-end of organic sales growth outlook by 100 basis pointsRaising low-end of FY23 adjusted EPS outlook by $0.05 CHARLOTTE, N.C., May 03, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced its financial results for the first quarter of 2023. First quarter net sales of $978 million increased 0.9%, compared to $969 million in the first quarter of 2022. Net loss for the first quarter of

CHARLOTTE, N.C., April 05, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona") (NASDAQ:XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Wednesday, May 3, 2023, at 8:30 am ET to review its first quarter financial results. A presentation related to the call will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. Conference Call / Webcast Information  A live webcast will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. For those planning to participate on the call, please register at https://register.vevent.com/register

FY22 net sales decreased (7.3%) to $3,922 million, organic sales decreased (0.5%)FY22 GAAP EPS of ($4.41), adjusted EPS of $2.09Q4 net sales decreased (10.9%) to $983 million, organic sales decreased (2.6%)Q4 GAAP EPS of ($0.07), adjusted EPS of $0.46FY23 outlook: net sales of $3.85 - $3.95 billion, organic sales down (1%) to up 2%, adj. EPS range of $1.80 to $2.00 CHARLOTTE, N.C., Feb. 28, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced its financial results for the fourth quarter and full year 2022. Full year 2022 net sales of $3,922 million decreased (7.3%), compared to $4,231 million for the full year of 2021. Net loss

CHARLOTTE, N.C., Feb. 02, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona") (NASDAQ:XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Tuesday, February 28, 2023, at 8:30 am ET to review its fourth quarter and full year 2022 financial results. A presentation related to the call will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. Conference Call / Webcast Information  A live webcast will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. For those planning to participate on the call, please register at https://regis

Net sales decreased (8.9%) to $947 million, organic sales decreased (0.7%)GAAP EPS loss of ($5.01), adjusted EPS of $0.41 down (31.5%) year-over-yearOperating cash flow of $109 millionUpdated FY22 outlook: organic sales decline of ~(2%); adj. EPS range of $1.90 to $2.00 CHARLOTTE, N.C., Nov. 14, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced its financial results for the third quarter of 2022. Third quarter net sales of $947 million decreased (8.9%), compared to $1,040 million in the third quarter of 2021. Foreign currency translation negatively impacted sales by (8.2%). Net loss for the third quarter of 2022 was ($1,077)

CHARLOTTE, N.C., Nov. 09, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona") (NASDAQ:XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Monday, November 14, 2022, at 8:30 am ET to review its third quarter financial results. A presentation related to the call will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. Conference Call / Webcast Information  A live webcast will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. For those planning to participate on the call, please register at https://dpregister.com/sreg/10

Announces Restatements of Third Quarter 2021 and Full Year 2021 Financials Reports Select Preliminary Third Quarter 2022 Results CHARLOTTE, N.C., Nov. 01, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or "the Company") (NASDAQ:XRAY) today announced the completion of the previously disclosed internal investigation into certain financial reporting matters. The investigation was undertaken by the Audit and Finance Committee of the Dentsply Sirona Board of Directors (the "Audit and Finance Committee"). Its findings and the actions the Company is taking to address these findings and certain related financial reporting matters are discussed in a Current Report on Form 8-K (t

Net sales decreased (6.1%) to $965 million, organic sales decreased (1.4%)Operating income of $93 million, adjusted operating income of $153 millionEPS of $0.30, adjusted EPS decreased to $0.52 vs $0.72 in Q1 2021Operating cash flow increased to $93 million vs $49 million in Q1 2021Updated FY22 outlook: organic sales growth of 2% to 3%; adj. EPS range of $2.35 to $2.55Delays filing of Form 10-Q as previously communicated in the Company's filing of a Form 12b-25 CHARLOTTE, N.C., May 10, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced its preliminary financial results for the first quarter of 2022. First quarter net sales of

First quarter 2022 revenues of $6.1 billion; GAAP net-income of $3.7 billion and GAAP diluted EPS of $8.58Moderna reiterates its 2022 signed advance purchase agreements of approximately $21 billionCompany expects to have four programs in Phase 3 in the second quarter: Omicron-containing bivalent COVID booster, flu, RSV, CMVCAMBRIDGE, MA / ACCESSWIRE / May 4, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today reported financial results and provided business updates for the first quarter of fiscal year 2022."The Moderna team delivered a strong Q1 performance and I am thankful for the progress our team continues to make a

CHARLOTTE, N.C., May 02, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona") (NASDAQ:XRAY) today announced that its first quarter 2022 earnings conference call and live webcast will be held on Tuesday, May 10, 2022, at 8:30 am ET. The call had previously been scheduled for Thursday, May 5, 2022. A presentation related to the call will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. Conference Call / Webcast Information  The live webcast will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. For those planning to participate on the call, please dial +1-866-777-2509 for

CHARLOTTE, N.C., April 05, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona") (NASDAQ:XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Thursday, May 5, 2022 at 8:30 am ET to review its financial results. A presentation related to the call will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. Conference Call / Webcast Information  The live webcast will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. For those planning to participate on the call, please dial +1-877-370-7637 for domestic calls, or +1-629-228-0723 fo

FY21 net sales increased 27.2% to $4,251 million, organic sales increased 24.6%FY21 operating income of $622 million, adjusted operating income increased 62.3% to $871 million FY21 EPS of $1.91, adjusted EPS increased 60.3% to $2.87FY21 operating cash flow increased to $657 million vs $635 million in FY20Q4 net sales increased 0.6% to $1,088 million, organic sales increased 1.8%Q4 operating income of $154 million, adjusted operating income decreased 13.7% to $217 million FY22 outlook: organic sales growth 4% to 5%, adjusted EPS range of $3.05 to $3.25 CHARLOTTE, N.C., Feb. 28, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced

CHARLOTTE, N.C., Feb. 04, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona") (NASDAQ:XRAY), announced today that the Company will be hosting an investor conference call and live webcast on Monday, February 28, 2022 at 8:30 am ET to review its financial results. A presentation related to the call will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. Conference Call / Webcast Information  The live webcast will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. For those planning to participate on the call, please dial +1-877-370-7637 for domestic calls, or +1-629-228-072

Revenue increased 19.4% to $1,069 million. Organic revenue increased 21.1%GAAP EPS increased to $0.47 vs $0.25 in 2020Non-GAAP EPS increased to $0.68 vs $0.67 in 2020GAAP operating income increased to $159 million vs $82 million in 2020Non-GAAP operating income increased to $216 million vs $197 million in 2020Operating cash flow decreased to $172 million vs $207 million in 2020FY21 Non-GAAP EPS outlook range raised to $2.87 to $2.92 CHARLOTTE, N.C., Nov. 04, 2021 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced its financial results for the third quarter of 2021. Third quarter net sales of $1,069 million increased 19.4%, comp

CHARLOTTE, N.C., Oct. 06, 2021 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona") (NASDAQ:XRAY), announced today that the Company will be hosting an investor conference call and live webcast on Thursday, November 4, 2021 at 8:30 am ET to review its financial results. A presentation related to the call will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. Conference Call / Webcast Information  The live webcast will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. For those planning to participate on the call, please dial +1-877-370-7637 for domestic calls, or +1-629-228-07

Revenue increased 117.3% to $1,067 million. Organic revenue increased 104.6%GAAP EPS increased to $0.45 vs loss of ($0.44) in 2020Non-GAAP EPS increased to $0.71 vs loss of ($0.18) in 2020GAAP operating income increased to $155 million vs loss of ($104) million in 2020Non-GAAP operating income increased to $219 million vs loss of ($42) million in 2020Operating cash flows increased to $214 million vs $175 million in 2020Reaffirm FY21 Non-GAAP EPS outlook of $2.75 to $2.90 CHARLOTTE, N.C., Aug. 05, 2021 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced its financial results for the second quarter of 2021. Second quarter net sales of

Revenue increased 17.5% to $1,027 million. Organic revenue increased 12.1%GAAP EPS increased to $0.53 vs loss of ($0.63) in 2020Non-GAAP EPS increased 67.4% to $0.72 vs $0.43 in 2020GAAP operating income increased to $154 million vs loss of ($125) million in 2020Non-GAAP operating income increased 67.2% to $219 million vs $131 million in 2020Operating cash flows increased to $49 million vs loss of ($10) million in 2020Raises FY21 Non-GAAP EPS outlook to $2.75 to $2.90 from $2.60 to $2.80 CHARLOTTE, N.C., May 06, 2021 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY), The Dental Solutions Company, today announced its financial results for the first

Q4 revenue decreased 2.6% to $1.08 billion. Organic revenue decreased 3.3%Q4 GAAP EPS decreased 2.2% to $0.45Q4 Non-GAAP EPS increased 19.2% to $0.87  Q4 GAAP operating income decreased 1.5% to $135 million Q4 Non-GAAP operating income increased 13.1% to $251 million FY20 Generated strong operating cash flow of $635 millionFY20 GAAP EPS loss of $(0.38) FY20 Non-GAAP EPS of $1.79Provides FY21 Non-GAAP EPS outlook range of $2.60 to $2.80 CHARLOTTE, N.C., March 01, 2021 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY), The Dental Solutions Company, today announced its financial results for the fourth quarter and full year 2020. Fo